The Dangers of Non-Nicotine E-Cigarettes and Vitamin Vaping

Aug.25.2022
The Dangers of Non-Nicotine E-Cigarettes and Vitamin Vaping
Non-nicotine e-cigarette health claims, including cancer prevention, asthma treatment, and improved energy, are unproven and may be unsafe. FDA warns.

In the trend of electronic cigarettes in recent years, some people have started inhaling nicotine-free "healthy" products that are believed to boost energy and have various health benefits, including cancer-fighting abilities, treatment of conditions such as asthma and ADHD, and even prevention of anemia. However, the US Food and Drug Administration (FDA) issued a warning in late 2021 regarding these products, stating that "these claims are unsubstantiated, the products may be ineffective, a waste of money, and unsafe.


Electronic cigarettes have received negative attention due to their potential health effects on young people, especially companies like JUUL that produce a variety of flavors specifically attractive to young people. Many of the concerns are similar for non-nicotine electronic cigarettes.


Doctor Jorge Mercado at Langone Medical Center at New York University, specializing in pulmonary medicine, stated, "Just because one way of taking vitamins is safe doesn't mean another method of absorption is safe. The lungs are not the primary organ for drug absorption.


There is still much unknown about how various substances are absorbed by the lungs and react with cells. General research on e-cigarettes tends to focus on the potential harmful effects of flavorings in e-cigarette products. These health impacts include cellular toxicity, or toxicity to cells, oxidative stress, and inflammation. In a study on e-cigarettes and flavored e-cigarettes, the highest level of active oxidative stress was produced by Vitamin Vape B12. The study also observed inflammation in lung epithelial cells and macrophages, which are white blood cells that identify and destroy microbes and dead cells.


The manufacturer of Vitamin Vape B12 also produces another e-cigarette related to Vitamin B12 called Breath B12. In December 2021, the US Food and Drug Administration issued a warning to Vitamin Vape saying "the use of your 'B12 VITAMINVAPE' product has raised safety concerns, as the ingredients or impurities in the orally inhaled product may cause laryngospasm or bronchospasm, toxic to tissue in the upper or lower respiratory tract, or may be absorbed and result in adverse systemic effects or organ toxicity.


Many health products, such as supplements and vitamins, are not regulated by the United States Food and Drug Administration, partly because they are not classified as food or drugs.


The FDA has stated that in this case, the product is considered a "new drug" and therefore requires approval from the FDA, which regulates it.


However, some damage may have already occurred. Vitamin Vape continues to sell its products and has 18,000 followers on Instagram. The US Food and Drug Administration has issued warning letters to other companies that offer similar products, including VitaCig, Eagle Energy, NV Nutrition, and VitaStik. These companies have been asked to correct any illegal actions. If they do not comply, the FDA may take enforcement action to prevent the products from reaching consumers.


Announcement:


This article has been compiled based on third-party information and is intended for industry professionals to exchange and learn from.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of its content. The translation of this article is solely for the purpose of professional exchange and research within the industry.


Due to limitations in the translator's abilities, the translated article may not accurately convey the original message. Please refer to the original article for accuracy.


2FIRSTS fully aligns with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign-related views and stances.


Copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | IQOS ILUMA i REMIX Limited Edition Launches in Japan, Bringing New Design Elements to Heated Tobacco Devices
Product | IQOS ILUMA i REMIX Limited Edition Launches in Japan, Bringing New Design Elements to Heated Tobacco Devices
Philip Morris Japan (PM Japan) has introduced the IQOS ILUMA i REMIX Limited Edition series, including the IQOS ILUMA i Prime REMIX, IQOS ILUMA i REMIX and IQOS ILUMA i ONE REMIX devices. The limited-edition models were officially announced in Japan on June 9, 2026, and began a phased market rollout from June 10. Featuring gradient color designs and visual customization elements, the collection highlights PMI’s continued use of limited editions to enhance brand experience within its heated tobacco portfolio.
Innovation
Jul.21 by 2Firsts Perspectives
Product | JTI Expands Ploom Ecosystem as LYO Tobacco-Free Nicotine Sticks Roll Out Across Europe
Product | JTI Expands Ploom Ecosystem as LYO Tobacco-Free Nicotine Sticks Roll Out Across Europe
Japan Tobacco International (JTI) is expanding its Ploom heated product ecosystem with LYO tobacco-free nicotine sticks. Designed specifically for Ploom devices, LYO contains nicotine but no tobacco. Public information shows that the product has gradually entered several European markets, including Spain, Portugal and Germany, and was officially introduced in Romania in July 2026. The launch highlights JTI’s efforts to explore broader nicotine consumable formats beyond traditional tobacco-based sticks.
JTI
Jul.21 by 2Firsts Perspectives
FDA Foreign Tobacco Registration Proposal Could Strengthen ENDS Import Oversight, Azim Chowdhury Says
FDA Foreign Tobacco Registration Proposal Could Strengthen ENDS Import Oversight, Azim Chowdhury Says
FDA’s proposed rule requiring foreign tobacco manufacturers to register establishments and list products is more than routine paperwork, Keller and Heckman LLP partner Azim Chowdhury told 2Firsts. He said it could strengthen FDA’s import enforcement, inspections and market surveillance. Chinese e-cigarette OEM/ODM manufacturers, specification developers, brand owners and component suppliers may need to review their roles, product data and U.S. market authorization status.
Special Report
Jun.29
Argentina Updates Health Warning Rules to Include Vapes and Nicotine Pouches
Argentina Updates Health Warning Rules to Include Vapes and Nicotine Pouches
Argentina’s Ministry of Health has updated its health warning rules for tobacco and nicotine products, adding e-cigarettes, vapes, heated tobacco products, sticks and nicotine pouches to mandatory warning requirements.
Jul.08
South Korean Lawmaker Jeong Jin-wook Pushes Synthetic Nicotine Vape Probe, Highlighting Supply Chain and Tax Concerns
South Korean Lawmaker Jeong Jin-wook Pushes Synthetic Nicotine Vape Probe, Highlighting Supply Chain and Tax Concerns
South Korean lawmaker Jeong Jin-wook has again called for stronger government action against liquid synthetic nicotine vape manufacturers and sellers, alleging that some businesses may have avoided regulation through product labeling changes and corporate restructuring. According to Newsworks, JNILBO and other Korean reports, Jeong has held his third press conference on the issue, calling for a government-wide investigation. The dispute involves whether synthetic nicotine products should fall under tobacco regulations, tax implications and supply-chain transparency. South Korean government agencies have previously said some estimates of potential tax losses cannot be verified due to limited sales data.
Jul.27
EU Trade Department Faces Scrutiny Over Contacts With Tobacco Industry
EU Trade Department Faces Scrutiny Over Contacts With Tobacco Industry
European Ombudswoman Teresa Anjinho has opened an inquiry into how the European Commission’s Directorate-General for Trade handles interactions with the tobacco industry. The case follows a complaint from a civil society organisation that alleges regular, unnecessary and non-transparent contacts between DG TRADE and tobacco industry representatives, raising questions over compliance with the EU’s obligations under the WHO Framework Convention on Tobacco Control. The inquiry remains ongoing, and the Ombudswoman has not reached any finding of maladministration.
Aug.24